WesternU Working with Manufacturers to Develop and Test New Drugs

Pomona, CA - 01/27/1999 -- Through its Center for Drug Development and Evaluation (CDDE), Western University of Health Sciences (WesternU) has initiated its first clinical trial for a drug. The CDDE is testing a diabetes medication formulated by a regional pharmaceutical company.

The CDDE exists to help pharmaceutical, biotech, medical companies and researchers in their drug development process, said CDDE Director Krishna Kumar, MPharm, PhD, MPS.

"We are a true 'one-stop shop,'" Dr. Kumar said. "We can provide a wide variety of services quickly and cost-effectively through our organized and highly qualified team of scientists and clinicians and our state-of-the- art facilities."

Among the drug development processes the CDDE can perform are data analysis; submission to the Federal Drug Administration (FDA) for approval; clinical trial design and management; formulation and dosage form development; protocol design and approval; documentation and regulatory services; and others.

Negotiations with area and regional pharmaceutical companies are ongoing, Dr. Kumar added.

Opened last year and located in WesternU's College of Pharmacy, the CDDE is comprised of approximately 15,000 square feet of space dedicated to drug development research, and houses pre-clinical, formulation and analytical development research laboratories.

Dr. Kumar specializes in the development of pharmaceutical products and evaluation of their bioavailability, pharmacokinetics, safety and efficacy. He has worked as a consultant to the pharmaceutical industry in the United States and overseas. Last October/November, for the second year in a row, Dr. Kumar presented a three-day course in Switzerland and Slovenia to pharmaceutical academics and scientists on the differences in development criteria between the FDA and its various European counterparts.

In addition, Dr. Kumar is a board member of CORE21, an organization designed to bring academia and industry together within the Inland Empire.

For more information on the Center for Drug Development and Evaluation, contact Dr. Kumar at (909) 469-5601. You may also e-mail him at kkumar@westernu.edu.

You may also access information on the CDDE at WesternU's World Wide Web site at http://westernu.edu/cdde.html.


(To learn more about this news article please contact Public Affairs Department)
Go Back